Variant report
Variant | nsv517591 |
---|---|
Chromosome Location | chr11:5811966-5821573 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:9)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:9 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr11:5818545-5818706 | A549 | lung: | n/a | chr11:5818599-5818608 chr11:5818599-5818608 chr11:5818598-5818609 chr11:5818599-5818608 chr11:5818597-5818608 chr11:5818599-5818608 |
2 | CEBPB | chr11:5818464-5818701 | HepG2 | liver: | n/a | chr11:5818599-5818608 chr11:5818599-5818608 chr11:5818598-5818609 chr11:5818599-5818608 chr11:5818597-5818608 chr11:5818599-5818608 |
3 | MAFK | chr11:5819987-5820055 | H1-hESC | embryonic stem cell: | n/a | n/a |
4 | POLR2A | chr11:5815326-5815526 | MCF10A-Er-Src | breast: | n/a | n/a |
5 | POLR2A | chr11:5815698-5815775 | A549 | lung: | n/a | n/a |
6 | POLR2A | chr11:5816936-5817136 | MCF10A-Er-Src | breast: | n/a | n/a |
7 | POLR2A | chr11:5812962-5812985 | MCF10A-Er-Src | breast: | n/a | n/a |
8 | STAT3 | chr11:5816279-5816430 | MCF10A-Er-Src | breast: | n/a | n/a |
9 | STAT3 | chr11:5817607-5817807 | MCF10A-Er-Src | breast: | n/a | n/a |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
OR52N1 | TF binding region |
OR52N3P | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs4758404 | chr11:5812206-5812207 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs189200262 | chr11:5812210-5812211 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs114116507 | chr11:5812265-5812266 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs552517678 | chr11:5812277-5812278 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs574359231 | chr11:5812282-5812283 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs543262250 | chr11:5812288-5812289 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs540540465 | chr11:5812292-5812293 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs561422099 | chr11:5812294-5812295 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs181952548 | chr11:5812344-5812345 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs74621326 | chr11:5812354-5812355 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs11604743 | chr11:5812445-5812446 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs565499549 | chr11:5812483-5812484 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs532614388 | chr11:5812514-5812515 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs145330202 | chr11:5812562-5812563 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs570056075 | chr11:5812962-5812963 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs372223658 | chr11:5812964-5812965 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs553319816 | chr11:5812967-5812968 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs560809614 | chr11:5816966-5816967 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs1453427 | chr11:5816995-5816996 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs542989301 | chr11:5817053-5817054 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs564559643 | chr11:5817091-5817092 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs533412797 | chr11:5817112-5817113 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs151148452 | chr11:5817126-5817127 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs1453426 | chr11:5817127-5817128 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
25 | rs116752391 | chr11:5817136-5817137 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs77766484 | chr11:5817632-5817633 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs143204129 | chr11:5817682-5817683 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs73392222 | chr11:5817732-5817733 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs35186177 | chr11:5817786-5817787 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs73392226 | chr11:5817797-5817798 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs547801757 | chr11:5817805-5817806 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs147091209 | chr11:5818400-5818401 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs541718109 | chr11:5818411-5818412 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs78432302 | chr11:5818437-5818438 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs77107630 | chr11:5818487-5818488 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs376811674 | chr11:5818568-5818569 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs560194657 | chr11:5818585-5818586 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs527343350 | chr11:5818609-5818610 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs7949986 | chr11:5818616-5818617 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
40 | rs529905005 | chr11:5818634-5818635 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs374748025 | chr11:5818649-5818650 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs527807891 | chr11:5818654-5818655 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs548083025 | chr11:5818682-5818683 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs138183953 | chr11:5818792-5818793 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs547370818 | chr11:5818824-5818825 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs551843838 | chr11:5818874-5818875 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs567335263 | chr11:5818937-5818938 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs574627548 | chr11:5819988-5819989 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs541799979 | chr11:5819991-5819992 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs192178318 | chr11:5821060-5821061 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 19432969 | CNVD |
Alzheimer''s disease | 17576883 | CNVD |
Long-qt syndrome | 17576883 | CNVD |
Emphysema | 19352772 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Chordoma | 18071362 | CNVD |
Breast cancer | 16608533 | CNVD |
Cancer | 21183584 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Breast cancer | 17603634 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Melanoma | 18172304 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Wilms tumour | 21544195 | CNVD |
Parathyroid adenoma | 22454399 | CNVD |
Chordoma | 21602918 | CNVD |
Breast cancer | 21949216 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 19222835 | CNVD |
T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Beckwith-Wiedemann syndrome | 21518781 | CNVD |
Wilms tumour | 21518781 | CNVD |
Hepatoblastoma | 21518781 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Gastric cancer | 17908304 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Autism | 22495311 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Ovine squamous-cell carcinoma | 17599052 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioma | 17123091 | CNVD |
Lung cancer | 16773561 | CNVD |
Neuroblastoma | 21124317 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Lung cancer | 17086460 | CNVD |
Schizophrenia | 21399695 | CNVD |
Gastric cancer | 16891809 | CNVD |
Cancer | 17160897 | CNVD |
Multiple myeloma | 16616336 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21364760 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 23613489 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:5812200-5812600 | Enhancers | Fetal Brain Male | brain |
2 | chr11:5818400-5819000 | Enhancers | Primary neutrophils fromperipheralblood | blood |
3 | chr11:5821000-5821800 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
4 | chr11:5821000-5824400 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |